Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | A2F3R | LA |
residual pain in both biceps occurs with movement; residual pain in both Shoulder; General body pain/pain from the neck to both ankles; This non-serious case was reported by a consumer via call center representative and described the occurrence of general body pain in a 85-year-old male patient who received Herpes zoster (Shingrix) (batch number A2F3R, expiry date 26-OCT-2026) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). On 07-OCT-2024, the patient received the 2nd dose of Shingrix (left deltoid). On 07-DEC-2024, 61 days after receiving Shingrix, the patient experienced general body pain (Verbatim: General body pain/pain from the neck to both ankles). On an unknown date, the patient experienced muscle pain (Verbatim: residual pain in both biceps occurs with movement) and shoulder pain (Verbatim: residual pain in both Shoulder). The patient was treated with prednisone. The outcome of the general body pain was resolved and the outcome of the muscle pain and shoulder pain were not resolved. It was unknown if the reporter considered the general body pain, muscle pain and shoulder pain to be related to Shingrix. It was unknown if the company considered the general body pain, muscle pain and shoulder pain to be related to Shingrix. Additional Information: GSK Receipt Date: 19-FEB-2025 The patient self-reported this case. The reporter stated that two months after suspect vaccine administration reporter experienced pain from the neck to both ankles. Reporter went to his physician and was prescribed prednisone for the pain. Pain resolved in 2 days after taking Prednisone. Reporter stated that he had residual pain in both shoulders and both biceps that occurs with movement.